Advertisement
Advertisement


Medical News

FDA Extends Review for Salix Diarrhea Drug

May 1, 2012

The Food and Drug Administration has extended by three months the review date for an experimental pill to treat HIV treatment-related diarrhea, according to Salix Pharmaceuticals, the drug's maker. FDA had been scheduled to review the drug, crofelemer, on June 5. Salix said in a statement that FDA said it needs more time for a full review, although it did not ask for any additional studies.

Back to other news for May 2012

Adapted from:
Reuters
04.30.2012; Balaji Sridharan




This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Advertisement

The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.